Literature DB >> 8926284

Natural killing activities in chronic liver diseases and hepatocellular carcinoma.

K Ono1, Y Yamanaga, K Yamamoto, S I Koga, J Nishimura, H Nawata.   

Abstract

Previously we proposed a new analysis of natural killing activity, for comparison, employing an individual effector/target cell ratio according to the peripheral number of effector cells. Using this analysis, we studied natural killing activities in chronic liver diseases and hepatocellular carcinoma (HCC). The activity in chronic persistent hepatitis remained nearly at the level of the nonactivated state, but that was significantly elevated in chronic active hepatitis. The activity in liver cirrhosis (LC) of Child's A or B grade was at the level of a nonactivated or reduced-activity state, while LC patients with impaired general conditions showed significantly elevated activities. In HCC, each of which was accompanied by LC in our cases, the activity appeared to be associated with the progression of HCC. Thus, natural killing activity showed a close relationship with the condition of chronic liver diseases.

Entities:  

Mesh:

Year:  1996        PMID: 8926284     DOI: 10.1007/bf01540971

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  20 in total

1.  Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver.

Authors:  T Nakajima; N Mizushima; K Kanai
Journal:  Jpn J Clin Oncol       Date:  1987-12       Impact factor: 3.019

2.  Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.

Authors:  T Wada; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-06

3.  Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.

Authors:  H Hirofuji; S Kakumu; A Fuji; Y Ohtani; K Murase; H Tahara
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

4.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

5.  Markers of viral replication in patients with chronic hepatitis B virus infection.

Authors:  S Govindarajan; T L Fong; B Valinluck; V Edwards; A G Redeker
Journal:  Am J Clin Pathol       Date:  1988-02       Impact factor: 2.493

6.  Natural killing activity is associated with progression of gastric cancer.

Authors:  K Ono; Y Imazono; T Misawa; J Nishimura; H Nawata
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

7.  Relationship between histology, aminotransferase levels, and viral replication in chronic hepatitis B.

Authors:  C T Mills; E Lee; R Perrillo
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

8.  Effect of cianidanol on natural killer cell activity in patients with chronic B virus hepatitis.

Authors:  A Pár; J Szekeres-Bartho; S Pácsa; T Jávor
Journal:  Int J Clin Pharmacol Res       Date:  1987

9.  Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.

Authors:  H F Pross; M G Baines; P Rubin; P Shragge; M S Patterson
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

10.  An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus-induced chronic liver disease.

Authors:  L Montaño; F Aranguibel; M Boffill; A H Goodall; G Janossy; H C Thomas
Journal:  Hepatology       Date:  1983 May-Jun       Impact factor: 17.425

View more
  4 in total

1.  Clinical significance of natural killing activity in patients with advanced lymphoma.

Authors:  K Ono
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

2.  Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis.

Authors:  P D Hodgson; M D Grant; T I Michalak
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

3.  Natural killing activity in patients with spontaneous regression of malignant lymphoma.

Authors:  K Ono; M Kikuchi; N Funai; M Matsuzaki; Y Shimamoto
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

Review 4.  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Authors:  M Campoli; S Ferrone
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.